NCT00938405View on ClinicalTrials.gov

Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Diabetes Mellitus, Type 1Hyperlipidemias
Interventions
DRUG

Colesevelam HCl

3.75 gms/day of colesevelam HCl in the form of three 625 mg tablets with lunch and dinner or six 625mg tablets once daily with dinner.

DRUG

Placebo

Placebo: 3.75 gms/day in the form of three 625 mg tablets with lunch and dinner or six 625mg tablets once daily with dinner.

Trial Locations (1)

80045

Barbara Davis Center for Diabetes, Aurora

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT00938405 - Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter